Analysis of various types of liposarcomas treated with doxorubicin in vitro. While doxorubicin is an established chemotherapeutic for treating liposarcomas, the response to this drug is low. Results provide insight into the molecular basis of the resistance of liposarcomas to doxorubicin.
GPL96:
[HG-U133A] Affymetrix Human Genome U133A Array
Citation:
Daigeler A, Klein-Hitpass L, Chromik MA, Müller O et al. Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures. BMC Cancer 2008 Oct 29;8:313. PMID: 18959781
